NSB 2.56% 4.0¢ neuroscientific biopharmaceuticals ltd

Valid concern! From the Ann: Investor Webinar Presentation on...

  1. 125 Posts.
    lightbulb Created with Sketch. 228
    Valid concern! From the Ann: Investor Webinar Presentation on the 17/11/21 they stated:

    https://hotcopper.com.au/data/attachments/4123/4123531-2379a155bdcaaa028926a976e722bdb5.jpg

    Mind you this includes both the FIH trial for Alzheimer's and the FIP trial for Glaucoma. It would be very disappointing should a CR be required before either of these outcomes. $3m spend in the last quarter on pre-clinical activities seems high, lets hope some of this is upfront expenditure for the trials


 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $5.784M
Open High Low Value Volume
3.9¢ 4.0¢ 3.6¢ $5.263K 142.7K

Buyers (Bids)

No. Vol. Price($)
2 20181 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 125000 1
View Market Depth
Last trade - 15.40pm 28/06/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.